Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Man Study to Evaluate Safety and Efficacy of Left Atrial Appendage Pulsed Field Ablation Occluder for Simultaneous Pulsed Field Ablation and Mechanical Closure of the Left Atrial Appendage in Patients With Nonvalvular Atrial Fibrillation

NCT05731882 is registered in ClinicalTrials.gov with Hangzhou Dinova EP Technology Co., Ltd as lead sponsor.

NCT NCT05731882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05731882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Man Study to Evaluate Safety and Efficacy of Left Atrial Appendage Pulsed Field Ablation Occluder for Simultaneous Pulsed Field Ablation and Mechanical Closure of the Left Atrial Appendage in Patients With Nonvalvular Atrial Fibrillation
Lead sponsor
Hangzhou Dinova EP Technology Co., Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
July 17, 2022
Completion date
August 1, 2024
Enrollment
10 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

nonvalvular atrial fibrillation